Accuracy of MRI and 18F‐FDG PET/CT for Restaging After Preoperative Concurrent Chemoradiotherapy for Rectal Cancer
Authors:
- 13 October 2009
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 33 (12) , 2688-2694
Abstract
Background: Performing a restaging work‐up with magnetic resonance imaging (MRI) and 18F‐fluorodeoxyglucose‐positron emission tomography/computed tomography (18F‐FDG PET/CT) can provide information about the effects that are related to preoperative concurrent chemoradiotherapy (CCRT). The purpose of the present study was to investigate the accuracy of MRI and 18F‐FDG PET/CT for restaging after preoperative CCRT for rectal cancer.Methods: Between April 2005 and February 2006, 30 patients with histologically proven rectal adenocarcinoma were included in this study. Pelvic MRI and 18F‐FDG PET/CT were performed to clinically restage the tumor after CCRT. The results of the pathologic staging were correlated with those of the MRI and 18F‐FDG PET/CT after CCRT. Two patients underwent transanal endoscopic microsurgery after CCRT, and they were excluded when the N category was evaluated.Results: The overall accuracy of MRI for the T category was 67% (κ = 0.422, P = 0.003), whereas overstaging and understaging occurred in 30 and 3% of the patients, respectively. For the N category, accurate staging was noted in 75% (κ = 0.410, P = 0.030) of all the patients, whereas 14% were overstaged and 11% were understaged. The overall accuracy rates for the T and N categories with performing 18F‐FDG PET/CT were 60% (κ = 0.372, P = 0.004) and 71% (κ = 0.097, P = 0.549), respectively. While MRI could not predict any patient who showed a pathologic complete response, 18F‐FDG PET/CT predicted three of the four patients who showed a pathologic complete response after preoperative CCRT. Furthermore, 18F‐FDG PET/CT identified distant metastases with an accuracy rate of 97%.Conclusions: For restaging patients with rectal cancer after preoperative CCRT, MRI is a useful diagnostic modality to predict both the T and N categories. 18F‐FDG PET/CT is helpful in predicting a pathologic complete response and in finding metastasis after preoperative CCRT.Keywords
This publication has 44 references indexed in Scilit:
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1Journal of the American College of Surgeons, 2004
- Value of Positron Emission Tomography With [F-18]Fluorodeoxyglucose in Patients With Colorectal Liver Metastases: A Prospective StudyJournal of Clinical Oncology, 2002
- Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional ExperienceAnnals of Surgery, 2001
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999
- Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.American Journal of Roentgenology, 1997
- Assessment of rectal tumor infiltration utilizing endorectal MR imaging and comparison with endoscopic rectal sonographyJournal of Surgical Oncology, 1997
- Magnetresonanztomographie und Endosonographie beim präoperativen Staging fortgeschrittener Rektumkarzinome nach HyperthermoradiochemotherapieRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1997
- Elevated Levels of Glucose Transport and Transporter Messenger RNA Are Induced by ras or src OncogenesScience, 1987
- PREDICTION OF OUTCOME AFTER CURATIVE RESECTION FOR LARGE BOWEL CANCERThe Lancet, 1986